Picture of Biovaxys Technology logo

BIOV Biovaxys Technology Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Biovaxys Technology, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

2018
October 31st
2019
October 31st
2020
October 31st
2021
October 31st
Period Length:
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Cash
Cash and Short Term Investments0.0160.2292.420.593
Net Total Receivables0.0030.0020.0480.133
Prepaid Expenses
Total Current Assets0.0340.2313.060.874
Net Property, Plant And Equipment0.0750.0750
Net Intangible Assets
Long Term Notes Receivable
Total Assets0.1090.30610.58.5
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.1850.1160.90.327
Total Long Term Debt
Total Debt
Total Liabilities0.1850.1160.90.327
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity-0.0760.199.568.18
Total Liabilities & Shareholders' Equity0.1090.30610.58.5
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email